SEC Form 4 · accession 0001140361-15-018559
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Robert Ajer
Officer — SVP, Chief Commercial Of
Period of report
Apr 30, 2015
Accepted (ET)
May 8, 2015 · 5:49 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 30, 2015 | A | 943 | $51.2635 | A | 43,033 | D | |
| Common Stock | May 6, 2015 | M | 12,502 | $38.59 | A | 55,535 | D | |
| Common Stock | May 6, 2015 | M | 625 | $21.51 | A | 56,160 | D | |
| Common Stock | May 6, 2015 | M | 3,125 | $21.51 | A | 59,285 | D | |
| Common Stock | May 6, 2015 | M | 2,642 | $28.23 | A | 61,927 | D | |
| Common Stock | May 6, 2015 | M | 5,258 | $28.23 | A | 67,185 | D | |
| Common Stock | May 6, 2015 | M | 808 | $37.46 | A | 67,993 | D | |
| Common Stock | May 6, 2015 | M | 8,671 | $37.46 | A | 76,664 | D | |
| Common StockF2 | May 6, 2015 | S | 33,631 | $119.1399 | D | 43,033 | D | |
| Common StockF3 | May 6, 2015 | S | 388 | $119.195 | D | 42,645 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Common StockF5,F4 | $38.59 | May 6, 2015 | M | 12,502 | D | Nov 22, 2008 | May 21, 2018 | Common Stock | 12,502 | 0 | D |
| Stock Option (right to buy) Common StockF5,F6 | $21.51 | May 6, 2015 | M | 625 | D | Nov 12, 2010 | Nov 11, 2020 | Common Stock | 625 | 0 | D |
| Stock Option (right to buy) Common StockF5,F6 | $21.51 | May 6, 2015 | M | 3,125 | D | Nov 12, 2010 | Nov 11, 2020 | Common Stock | 3,125 | 0 | D |
| Stock Option (right to buy) Common StockF5,F7 | $28.23 | May 6, 2015 | M | 2,642 | D | Dec 1, 2011 | May 30, 2021 | Common Stock | 2,642 | 978 | D |
| Stock Option (right to buy) Common StockF5,F7 | $28.23 | May 6, 2015 | M | 5,258 | D | Dec 1, 2011 | May 30, 2021 | Common Stock | 5,258 | 0 | D |
| Stock Option (right to buy) Common StockF5,F7 | $37.46 | May 6, 2015 | M | 808 | D | Nov 8, 2012 | May 7, 2022 | Common Stock | 808 | 1,355 | D |
| Stock Option (right to buy) Common StockF5,F8 | $37.46 | May 6, 2015 | M | 8,671 | D | Nov 8, 2012 | May 7, 2022 | Common Stock | 8,671 | 2,166 | D |
Explanation of responses
- F1The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2014 to April 30, 2015.
- F2The price in column 4 is an average weighted price. The price actually received ranged from $119.00 to $119.39. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
- F3All shares sold at same price
- F4Option grant vests 6/48ths on November 22, 2008, and 1/48th on the 22nd day of every month thereafter.
- F5Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
- F6Option grant vests 6/48ths on November 12, 2010, and 1/48th on the 12th day of every month thereafter.
- F7Option grant vests 6/48ths on December 1, 2011, and 1/48th on the 1st day of every month thereafter.
- F8Option grant vests 6/48ths on November 8, 2012, and 1/48th on the 12th day of every month thereafter.